VAERS reports by lot

GSK Hepatitis A lot 42B22: VAERS reports

28 VAERS reports list lot 42B22 as a GSK Hepatitis A vaccine, received between 2024-06-12 and 2026-03-16. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological133%
Dermatological (non-injection-site)133%
General / Systemic (non-local)133%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
New Jersey6
Michigan5
Kentucky3
Arizona2
Colorado2
Maine1
Kansas1
New York1
Virginia1
South Dakota1
North Carolina1
Louisiana1

Reports by month received

MonthReportsBar
2024-063
2024-072
2024-084
2024-093
2024-121
2025-011
2025-025
2025-032
2025-042
2025-051
2025-071
2025-081
2025-111
2026-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 3A22R · 3J9G4 · 423NL · 47XP4 · 4EA77 · 4H37Y

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.